Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html

Study Counts

Type Study_count
Total_Studies 105
interventional 92
Observational 11
Registry 2

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 34
Drug|Other 12
Device 11
Procedure 7
Biological|Drug 4
Drug|Other|Procedure 4
Drug|Procedure 3
Drug|Radiation 3
Behavioral|Other 2
Biological 2
Dietary Supplement 2
Other 2
Biological|placebo 1
Combination Product|Drug 1
Device|Drug 1
Diagnostic Test 1
Drug|Genetic|Other 1
Drug|Genetic|Other|Procedure|Radiation 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 54
Korea, Republic of 8
France 5
Japan 4
United Kingdom 4
Germany 3
NA 3
Canada 2
Sweden 2
Denmark 1
France|Monaco 1
Hong Kong 1
Japan|Korea, Republic of 1
South Africa 1
Switzerland 1
United States|Canada 1

Sites per Study

Site_count Study_Count
1 57
2 4
3 5
4 1
5 2
6 1
7 2
8 1
9 1
10 1
11 1
13 2
19 1
20 2
23 1
25 1
37 1
41 1
42 1
46 1
112 1
141 1
251 1
295 1
620 1

Phase

Phase Study_Count
Phase 2 33
N/A 21
Phase 1 16
Phase 3 8
Phase 1/Phase 2 7
Phase 4 4
Phase 2/Phase 3 3

Number of Arms

Number_of_Arms Count_of_Studies
1 40
2 30
3 2
4 3
5 2
7 1
NA 14

Enrollment Metrics by Phase

Measure N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 5.0000 7.00000 17 4.00000 34.0 92.00 40.0
1st Qu. 50.0000 22.50000 48 23.00000 164.5 243.25 47.5
Median 71.0000 36.00000 68 41.00000 295.0 296.00 85.0
Mean 109.4286 42.86667 65 43.96667 215.0 297.50 152.5
3rd Qu. 150.0000 48.50000 82 57.00000 305.5 371.25 190.0
Max. 400.0000 108.00000 110 105.00000 316.0 480.00 400.0

Trial Group Type

group_type Group_Count
Experimental 95
Active Comparator 29
NA 14
Other 5
No Intervention 3
Placebo Comparator 2
Sham Comparator 1

Intervention Model

intervention_model Study_Count
Single Group Assignment 45
Parallel Assignment 30
NA 12
Sequential Assignment 4
Crossover Assignment 1

Primary Purpose

primary_purpose Study_Count
Treatment 74
Supportive Care 9
Diagnostic 4
Prevention 4
Other 1

Observational Studies

Studies by Country

Country Study_Count
United States 6
France 2
Germany 1
NA 1
United States|France|Germany 1

Sites per Study

Site_count Study_Count
1 10
6 1

Enrollment Metrics

Measure Observational
Min 30.0000
1st Qu 85.0000
Median 144.0000
Mean 775.5455
3rd Qu 408.5000
Max 6000.0000

Observation Model

observational_model Study_Count
Cohort 5
Case-Only 2
NA 2
Case-Control 1
Other 1

Time Perspective

time_perspective Study_Count
Prospective 9
Retrospective 1
NA 1

Registries

Studies by Country

Country Study_Count
Canada 1
United States 1

Sites per Study

Site_count Study_Count
1 1
75 1

Enrollment Metrics

Measure Registries
Min 2000.0
1st Qu 251499.8
Median 500999.5
Mean 500999.5
3rd Qu 750499.2
Max 999999.0

Registry Model

observational_model Study_Count
Case-Control 1
Cohort 1

Time Perspective

time_perspective Study_Count
Prospective 2

Follow-up

target_duration Study_Count
5 Years 1
80 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03821025 Self-expandable Metal Stents Versus Multiple Plastic Stents for Palliation of Biliary Obstruction https://ClinicalTrials.gov/show/NCT03821025 Recruiting University of Cape Town 2020-12-31
NCT03111732 Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC) https://ClinicalTrials.gov/show/NCT03111732 Recruiting National Institutes of Health Clinical Center (CC) 2020-12-31
NCT03086993 Percutaneous Hepatic Perfusion vs. Cisplatin/Gemcitabine in Patients With Intrahepatic Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT03086993 Recruiting Delcath Systems Inc. 2023-01-31
NCT03058289 A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6 https://ClinicalTrials.gov/show/NCT03058289 Recruiting Intensity Therapeutics, Inc. 2022-07-31
NCT03044587 Nal-IRI With 5-fluorouracil (5-FU) and Leucovorin or Gemcitabine Plus Cisplatin in Advanced Biliary-tract Cancer https://ClinicalTrials.gov/show/NCT03044587 Recruiting AIO-Studien-gGmbH 2019-12-31
NCT03003065 Safety and Tumoricidal Effect of Low Dose Foscan PDT in Patients With Inoperable Bile Duct Cancers https://ClinicalTrials.gov/show/NCT03003065 Recruiting Chinese University of Hong Kong 2022-08-31
NCT02958059 Effectiveness of Prophylactic Antibiotics to Prevent Post Endoscopic Retrograde Cholangio Pancreatography Bacteremia in Biliary Obstruction Patient https://ClinicalTrials.gov/show/NCT02958059 Recruiting Yonsei University 2020-08-31
NCT02853474 Early Palliative Care in Patients With Metastatic Upper Gastrointestinal Cancers Treated With First-line Chemotherapy https://ClinicalTrials.gov/show/NCT02853474 Recruiting Centre Oscar Lambret 2021-10-31
NCT02841800 Intra-luminal Radiofrequency Ablation for Inoperable Malignant Biliary Stenosis https://ClinicalTrials.gov/show/NCT02841800 Completed National Taiwan University Hospital 2018-08-30
NCT02821754 A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC) https://ClinicalTrials.gov/show/NCT02821754 Recruiting National Institutes of Health Clinical Center (CC) 2020-12-31
NCT02591030 Safety and Efficacy of Modified Folfirinox Versus Gemcis in Bile Duct Tumours https://ClinicalTrials.gov/show/NCT02591030 Recruiting Centre Hospitalier Universitaire de Saint Etienne 2023-09-30
NCT02575014 Pancreaticoduodenectomy With or Without Preoperative Hyperbaric Oxygen Therapy https://ClinicalTrials.gov/show/NCT02575014 Enrolling by invitation Florida Hospital Tampa Bay Division 2018-12-31
NCT04298021 DDR-Umbrella Study of DDR Targeting Agents in Advanced Biliary Tract Cancer https://ClinicalTrials.gov/show/NCT04298021 Recruiting Seoul National University Hospital 2021-03-31
NCT04298008 AZD6738 Plus Durvalumab in Biliary Tract Cancer https://ClinicalTrials.gov/show/NCT04298008 Recruiting Seoul National University Hospital 2021-03-31
NCT02375880 Study of DKN-01 and Gemcitabine/Cisplatin in Patients With Carcinoma to Primary to the Intra- or Extra-Hepatic Biliary System or Gallbladder https://ClinicalTrials.gov/show/NCT02375880 Completed Leap Therapeutics, Inc. 2018-07-31
NCT02349412 Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers https://ClinicalTrials.gov/show/NCT02349412 Completed Alliance for Clinical Trials in Oncology 2017-07-03
NCT02293954 Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer https://ClinicalTrials.gov/show/NCT02293954 Active, not recruiting City of Hope Medical Center 2020-06-30
NCT02115542 Single Agent Regorafenib in Refractory Advanced Biliary Cancers https://ClinicalTrials.gov/show/NCT02115542 Active, not recruiting H. Lee Moffitt Cancer Center and Research Institute 2018-12-10
NCT02088775 PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary Cancer https://ClinicalTrials.gov/show/NCT02088775 Active, not recruiting Fox Chase Cancer Center 2016-09-08
NCT01313377 Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery https://ClinicalTrials.gov/show/NCT01313377 Completed UNICANCER 2016-06-30
NCT02042443 Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery https://ClinicalTrials.gov/show/NCT02042443 Completed National Cancer Institute (NCI) 2017-01-31
NCT01954745 Cabozantinib (XL-184) Monotherapy for Advanced Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT01954745 Completed Massachusetts General Hospital 2015-06-30
NCT01845337 Study to Compare Cardiovascular Side Effects of Teysuno Versus Capecitabine https://ClinicalTrials.gov/show/NCT01845337 Active, not recruiting University of Edinburgh 2021-07-30
NCT01766219 CPI-613 in Treating Patients With Advanced or Metastatic Bile Duct Cancer That Cannot Be Removed By Surgery https://ClinicalTrials.gov/show/NCT01766219 Completed Wake Forest University Health Sciences 2018-04-30
NCT01643499 Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies https://ClinicalTrials.gov/show/NCT01643499 Completed University of Chicago 2016-08-28
NCT01640522 Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms https://ClinicalTrials.gov/show/NCT01640522 Completed University of Pittsburgh 2013-12-31
NCT01534637 Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Chemotherapy and Radiation Therapy for Pancreatic Cancer https://ClinicalTrials.gov/show/NCT01534637 Completed Wake Forest University Health Sciences 2009-12-31
NCT01459965 Stenting Malignant Jaundice for Quality of Life https://ClinicalTrials.gov/show/NCT01459965 Completed Indiana University 2004-11-30
NCT01425879 MK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by Surgery https://ClinicalTrials.gov/show/NCT01425879 Completed National Cancer Institute (NCI) 2013-05-31
NCT04404647 Irreversible Electroporation of Unresectable Liver Tumors https://ClinicalTrials.gov/show/NCT04404647 Recruiting Aalborg University Hospital 2025-03-30
NCT04337333 Two-in-one Covered and Uncovered Metal Stent https://ClinicalTrials.gov/show/NCT04337333 Recruiting Ajou University School of Medicine 2020-12-31
NCT04276090 Codman Catheter/Synchromed Pump Hepatic Artery Chemotherapy for Unresectable Colorectal Metastases/Intrahepatic Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT04276090 Recruiting University of Kentucky 2023-05-01
NCT04152018 Study of PF‑06940434 in Patients With Advanced or Metastatic Solid Tumors. https://ClinicalTrials.gov/show/NCT04152018 Recruiting Pfizer 2024-03-02
NCT04076761 Study of TRIFLURIDINE/TIPIRACIL in Previously Treated Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT04076761 Recruiting Sunnybrook Health Sciences Centre 2021-09-30
NCT04072445 Trifluridine/Tipiracil and Irinotecan for the Treatment of Advanced Refractory Biliary Tract Cancer https://ClinicalTrials.gov/show/NCT04072445 Recruiting Mayo Clinic 2021-05-15
NCT03768414 Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers https://ClinicalTrials.gov/show/NCT03768414 Recruiting Southwest Oncology Group 2024-01-01
NCT03763214 PTFE Stents for Treatment of Malignant Biliary Strictures https://ClinicalTrials.gov/show/NCT03763214 Recruiting Johann Wolfgang Goethe University Hospital 2020-03-31
NCT03708445 Development of a New Immunochemistry Method Using Antibodies of Proteins Related Bile Duct Cancer https://ClinicalTrials.gov/show/NCT03708445 Completed Gangnam Severance Hospital 2020-01-22
NCT03679338 Prospective Evaluation of the Ablation Therapy With Bipolar Radio Frequency for Nonresectable Bile Duct Cancer https://ClinicalTrials.gov/show/NCT03679338 Recruiting Institut Paoli-Calmettes 2020-11-30
NCT03602079 Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene https://ClinicalTrials.gov/show/NCT03602079 Recruiting Klus Pharma Inc. 2020-10-31
NCT03475966 Improving Outcomes in Cancer Patients With a Nutritional and Physical Conditioning Prehabilitation Program https://ClinicalTrials.gov/show/NCT03475966 Recruiting McGill University Health Centre/Research Institute of the McGill University Health Centre 2019-12-31
NCT03447691 Comparison Between Volatile Anesthetic-desflurane and Total Intravenous Anesthesia With Propofol and Remifentanil on Early Recovery Quality and Long Term Prognosis of Patients Undergoing Pancreatic Cancer and Common Bile Duct Cancer Surgery https://ClinicalTrials.gov/show/NCT03447691 Recruiting Yonsei University 2022-08-28
NCT01256047 Effects of Preoperative Immunonutrition in Patients Undergoing Hepatectomy https://ClinicalTrials.gov/show/NCT01256047 Completed Chiba University 2014-03-31
NCT01256034 Effects of Preoperative Immunonutrition in Patients Undergoing Pancreaticoduodenectomy https://ClinicalTrials.gov/show/NCT01256034 Completed Chiba University 2012-03-31
NCT01232101 Covered or Uncovered Bile Duct Stents https://ClinicalTrials.gov/show/NCT01232101 Completed Göteborg University 2009-06-30
NCT01134276 Comparison Between Internal and External Preoperative Biliary Drainage in Periampullary Cancers https://ClinicalTrials.gov/show/NCT01134276 Completed Seoul National University Hospital 2013-05-31
NCT01093222 Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT01093222 Completed National Cancer Institute (NCI) 2012-09-30
NCT01041612 Comparing Covered Self-expandable Metallic Stent (SEMS) Above/Across the Sphincter of Oddi https://ClinicalTrials.gov/show/NCT01041612 Completed Taewoong Medical Co., Ltd. 2012-09-30
NCT00987766 Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer https://ClinicalTrials.gov/show/NCT00987766 Completed Vanderbilt-Ingram Cancer Center 2013-07-31
NCT00930410 Intra-ductal Confocal Endomicroscopy for Characterization of Pancreas and Bile Duct Tumor https://ClinicalTrials.gov/show/NCT00930410 Completed Institut Paoli-Calmettes 2012-05-31
NCT00919061 Gemcitabine and Cisplatin Plus Sorafenib in Patients With Advanced Biliary Tract Carcinomas Naive to Systemic Therapy https://ClinicalTrials.gov/show/NCT00919061 Completed Memorial Sloan Kettering Cancer Center 2014-03-31
NCT01683240 Prospective Multicenter Evaluation of a New Short-access-cholangioscope for Biliary Duct Strictures and Gall Stones https://ClinicalTrials.gov/show/NCT01683240 Completed Universitätsklinikum Hamburg-Eppendorf 2016-02-29
NCT02028845 Loop-tipped Guidewire in Selective Biliary Cannulation https://ClinicalTrials.gov/show/NCT02028845 Completed Ajou University School of Medicine 2015-12-31
NCT00789958 S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct https://ClinicalTrials.gov/show/NCT00789958 Completed Southwest Oncology Group 2014-12-31
NCT00654160 Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT00654160 Completed Mayo Clinic 2010-11-30
NCT00639314 Trial on the Evaluation of Pylorus-ring in Pancreaticoduodenectomy https://ClinicalTrials.gov/show/NCT00639314 Completed Wakayama Medical University 2009-05-31
NCT00634751 CO07204-Phase I/II of Oxaliplatin, Capecitabine & Sorafenib for Advanced Pancreatic & Biliary Carcinoma https://ClinicalTrials.gov/show/NCT00634751 Completed University of Wisconsin, Madison 2010-07-31
NCT00628186 Randomized Controlled Trial on Pancreatic Stent Tube in Pancreaticoduodenectomy https://ClinicalTrials.gov/show/NCT00628186 Completed Wakayama Medical University 2007-08-31
NCT00553332 Selumetinib in Treating Patients With Biliary Cancer That Cannot Be Removed By Surgery https://ClinicalTrials.gov/show/NCT00553332 Completed National Cancer Institute (NCI) 2013-01-31
NCT00544193 Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT00544193 Completed City of Hope Medical Center 2012-08-31
NCT00513539 Biliary Stenting With or Without Photodynamic Therapy in Treating Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors That Cannot Be Removed by Surgery https://ClinicalTrials.gov/show/NCT00513539 Completed University College, London 2009-12-31
NCT00486356 Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer https://ClinicalTrials.gov/show/NCT00486356 Completed University of Nebraska 2010-01-31
NCT00397384 Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer https://ClinicalTrials.gov/show/NCT00397384 Completed National Cancer Institute (NCI) 2013-06-30
NCT00363584 Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer https://ClinicalTrials.gov/show/NCT00363584 Completed National Cancer Institute (NCI) 2013-08-31
NCT00356889 Bevacizumab and Erlotinib Hydrochloride in Treating Patients With Metastatic or Unresectable Biliary Tumors https://ClinicalTrials.gov/show/NCT00356889 Completed National Cancer Institute (NCI) 2008-10-31
NCT00304135 Fluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmetastatic Biliary Tract Cancer That Cannot Be Removed By Surgery https://ClinicalTrials.gov/show/NCT00304135 Completed Federation Francophone de Cancerologie Digestive 2012-12-31
NCT00280709 Biliary Metal Stent Study: Metal Stents for Management of Distal Malignant Biliary Obstruction https://ClinicalTrials.gov/show/NCT00280709 Completed University Hospital, Linkoeping 2008-10-31
NCT00266097 Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer https://ClinicalTrials.gov/show/NCT00266097 Completed UNC Lineberger Comprehensive Cancer Center 2009-03-31
NCT00262769 Gemcitabine With or Without Cisplatin in Treating Patients With Unresectable Locally Advanced or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors https://ClinicalTrials.gov/show/NCT00262769 Completed University College, London 2008-08-31
NCT00238212 S0514 Sorafenib in Treating Patients With Unresectable or Metastatic Gallbladder Cancer or Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT00238212 Completed National Cancer Institute (NCI) 2007-01-31
NCT00183846 Study of Irinotecan Administered as a Continuous Infusion and Radiation Therapy for Upper Gastrointestinal Cancers https://ClinicalTrials.gov/show/NCT00183846 Completed University of Southern California 2007-10-31
NCT00107536 Lapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract Cancer https://ClinicalTrials.gov/show/NCT00107536 Completed National Cancer Institute (NCI) 2009-05-31
NCT00101036 Lapatinib in Treating Patients With Locally Advanced or Metastatic Biliary Tract or Liver Cancer That Cannot Be Removed By Surgery https://ClinicalTrials.gov/show/NCT00101036 Completed National Cancer Institute (NCI) 2009-01-31
NCT00003557 Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancer https://ClinicalTrials.gov/show/NCT00003557 Completed University of Chicago 2000-06-30
NCT00084942 Gemcitabine and Capecitabine in Treating Patients With Advanced and/or Inoperable Cholangiocarcinoma or Carcinoma of the Gallbladder https://ClinicalTrials.gov/show/NCT00084942 Completed Roswell Park Cancer Institute 2004-05-31
NCT00004604 Biological Therapy in Treating Patients With Metastatic Cancer https://ClinicalTrials.gov/show/NCT00004604 Completed Duke University 2001-06-30
NCT00003427 Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT00003427 Completed Memorial Sloan Kettering Cancer Center 2002-04-30
NCT00005938 DX-8951f in Treating Patients With Biliary Cancer https://ClinicalTrials.gov/show/NCT00005938 Completed Daiichi Sankyo, Inc. 2005-04-30
NCT00019474 Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer https://ClinicalTrials.gov/show/NCT00019474 Completed Montefiore Medical Center 2000-08-31
NCT00003411 Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer https://ClinicalTrials.gov/show/NCT00003411 Completed University of Pittsburgh 2002-06-30
NCT00003923 Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or Pancreas https://ClinicalTrials.gov/show/NCT00003923 Completed Memorial Sloan Kettering Cancer Center 2002-02-28
NCT00009893 Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer https://ClinicalTrials.gov/show/NCT00009893 Completed Alliance for Clinical Trials in Oncology 2005-01-31
NCT00073905 Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract Cancer https://ClinicalTrials.gov/show/NCT00073905 Completed Swiss Group for Clinical Cancer Research 2006-06-30
NCT00004074 Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu https://ClinicalTrials.gov/show/NCT00004074 Completed National Cancer Institute (NCI) 2009-02-28
NCT00033462 Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder Cancer https://ClinicalTrials.gov/show/NCT00033462 Completed National Cancer Institute (NCI) 2006-11-30
NCT00004910 Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction https://ClinicalTrials.gov/show/NCT00004910 Completed Northwestern University 2003-02-28
NCT00004895 Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery https://ClinicalTrials.gov/show/NCT00004895 Completed Northwestern University 2002-10-31
NCT00059865 Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer https://ClinicalTrials.gov/show/NCT00059865 Completed Alliance for Clinical Trials in Oncology 2007-02-28
NCT00033540 S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT00033540 Completed Southwest Oncology Group 2008-04-30
NCT00031681 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) https://ClinicalTrials.gov/show/NCT00031681 Completed National Cancer Institute (NCI) 2011-01-31
NCT00021047 Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor https://ClinicalTrials.gov/show/NCT00021047 Completed National Institutes of Health Clinical Center (CC) NA
NCT00019513 Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas https://ClinicalTrials.gov/show/NCT00019513 Completed National Institutes of Health Clinical Center (CC) NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03328065 Viewpoints on the Social Representations and Rationale Concerning the Choices of Patients, Doctors and Caregivers With Regard to the Management of Patients With Non-resectable Metastatic Cancer of the Colon, Stomach, Bile Ducts, Rectum or Lung, or Gastrointestinal Neuroendocrine Tumours https://ClinicalTrials.gov/show/NCT03328065 Recruiting Centre Hospitalier Universitaire Dijon 2020-12-31
NCT01915225 Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer https://ClinicalTrials.gov/show/NCT01915225 Recruiting National Institutes of Health Clinical Center (CC) 2027-06-30
NCT03951324 Volumetric Laser Endomicroscopy’s (VLE) Diagnostic Accuracy Validation Study: Impact on Clinical Management Study https://ClinicalTrials.gov/show/NCT03951324 Enrolling by invitation Innovative Digestive Health Education and Research Inc 2019-12-31
NCT03896958 The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) https://ClinicalTrials.gov/show/NCT03896958 Recruiting SpeciCare 2021-03-12
NCT03788655 Metal Stents (Moving Cell Stent) for Inoperable Tumors of the Bile Duct Tract https://ClinicalTrials.gov/show/NCT03788655 Recruiting Johann Wolfgang Goethe University Hospital 2020-12-31
NCT03525067 Colonization of Bile Ducts and Postoperative Infectious Complications of Pancreaticoduodenectomies https://ClinicalTrials.gov/show/NCT03525067 Completed Central Hospital, Nancy, France 2018-02-01
NCT00836992 Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT00836992 Completed Mayo Clinic 2011-09-15
NCT00779688 A Registry of Patients Undergoing Cellvizio Endomicroscopy and Endoscopic Retrograde Cholangiopancreatography(ERCP) Imaging Procedures for Diagnosing Pancreatic and Bile Duct Cancers https://ClinicalTrials.gov/show/NCT00779688 Completed Mauna Kea Technologies 2009-09-30
NCT00582647 Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract https://ClinicalTrials.gov/show/NCT00582647 Active, not recruiting Memorial Sloan Kettering Cancer Center 2020-12-31
NCT00579865 Quality Of Life in Patients With Malignant Biliary Obstruction https://ClinicalTrials.gov/show/NCT00579865 Completed Memorial Sloan Kettering Cancer Center 2010-01-31
NCT00559598 Blood Proteins in Finding Pancreatic Cancer and Extrahepatic Biliary Tract Cancer https://ClinicalTrials.gov/show/NCT00559598 Completed National Institutes of Health Clinical Center (CC) NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT02012699 Integrated Cancer Repository for Cancer Research https://ClinicalTrials.gov/show/NCT02012699 Recruiting University of Nebraska 2099-12-31
NCT04104230 Quebec Pancreas Cancer Study https://ClinicalTrials.gov/show/NCT04104230 Recruiting McGill University Health Centre/Research Institute of the McGill University Health Centre 2025-01-31